Effects of Low-calorie Diet on Steatohepatitis in Rats with Obesity and Hyperlipidemia

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2003 Sep 13

PMID 12970903

Citations 19

Authors

Jian-Gao Fan

Lan Zhong

Zheng-Jie Xu

Li-Yan Tia

Xiao-Dong Ding

Min-Sheng Li

Guo-Liang Wang

Affiliations

Soon will be listed here.

Abstract

Aim: To evaluate the effects of low calorie diet (LCD) on nonalcoholic steatohepatitis (NASH) in rats with obesity and hyperlipidemia.

Methods: 29 Sprague-Dawley (SD) rats were randomly divided into three groups. The animals in control (n=9) and NASH group (n=10) were fed on standard rat diet and high fat diet respectively for 12 weeks, ten rats in LCD group were fed on high fat diet for 10 weeks and then low calorie diet for 2 weeks. At the end of the experiment, body weight, abdominal adipose content, liver function, and hepatopathological changes were examined to evaluate the effect of different feeding protocols on the experimental animals.

Results: There was no death of animal in the experimental period. All rats in the NASH group developed steatohepatitis according to liver histological findings. Compared with the control group, body weight (423.5+/-65.2 vs 351.1+/-43.0 g, P<0.05), abdominal adipose content (14.25+/-1.86 vs 9.54+/-1.43, P<0.05), liver index (3.784+/-0.533 vs 2.957+/-0.301 %, P<0.01), total serum cholesterol (1.60+/-0.41 vs 1.27+/-0.17 mmol/L,P<0.05) and free fatty acids (728.2+/-178.5 vs 429.2+/-96.7 mmol/L, P<0.01), serum alanine aminotransferase (1,257.51+/-671.34 vs 671.34+/-118.57 nkat/L, P<0.05) and aspartic aminotransferase (2,760.51+/-998.66 vs 1,648.29+/-414.16 nkat/L, P<0.01) were significantly increased in the NASH group. Whereas, when rats were fed on LCD protocol, their body weight (329.5+/-38.4 g, P<0.01), abdominal adipose content (310.21+/-1.52 g, P<0.05), liver index (3.199+/-0.552 %, P<0.05), and serum alanine aminotransferase (683.03+/-245.49 nkat/L, P<0.05) were significantly decreased, and the degree of hepatic steatosis (P<0.05) was markedly improved compared with those in the NASH group. However, no significant difference was found in serum lipid variables and hepatic inflammatory changes between the two groups.

Conclusion: LCD might play a role in the prevention and treatment of obesity and hepatic steatosis in SD rats, but it exerts no significant effects on both serum lipid disorders and hepatic inflammatory changes.

Citing Articles

Transcriptomics Dissection of Calorie Restriction and Exercise Training in Brown Adipose Tissue and Skeletal Muscle.

Feng Y, Cui Z, Lu X, Gong H, Liu X, Wang H Nutrients. 2023; 15(4).

PMID: 36839405 PMC: 9966723. DOI: 10.3390/nu15041047.

Antioxidative potential and ameliorative effects of green lentil ( M.) sprouts against CCl-induced oxidative stress in rats.

Barakat H, Alshimali S, Almutairi A, Alkhurayji R, Almutiri S, Aljutaily T Front Nutr. 2022; 9:1029793.

PMID: 36438775 PMC: 9691994. DOI: 10.3389/fnut.2022.1029793.

Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats.

Zhao Z, Xin F, Xue Y, Hu Z, Han Y, Ma F Exp Mol Med. 2019; 51(9):1-14.

PMID: 31506421 PMC: 6802644. DOI: 10.1038/s12276-019-0304-5.

Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats.

Zhao Z, Xin F, Zhou D, Xue Y, Liu X, Yang R World J Gastroenterol. 2019; 25(20):2450-2462.

PMID: 31171889 PMC: 6543245. DOI: 10.3748/wjg.v25.i20.2450.

Volatile Oil of Inhibits Nonalcoholic Fatty Liver Disease via the Gut-Liver Axis.

Lu S, Zhang T, Gu W, Yang X, Lu J, Zhao R Biomed Res Int. 2018; 2018:3589874.

PMID: 30112382 PMC: 6077613. DOI: 10.1155/2018/3589874.

References

Fan J, Zeng M . [Classification and diagnostic strategies of nonalcoholic fatty liver diseases]. Zhonghua Gan Zang Bing Za Zhi. 2003; 11(2):127-8. View

Brunt E, Janney C, Di Bisceglie A, Neuschwander-Tetri B, Bacon B . Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999; 94(9):2467-74. DOI: 10.1111/j.1572-0241.1999.01377.x. View

Fan J, Xu M . [Relationship between fatty liver and atherosclerosis, and coronary atherosclerotic heart disease]. Zhonghua Gan Zang Bing Za Zhi. 2002; 10(2):150-1. View

Weltman M, Farrell G, Liddle C . Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology. 1996; 111(6):1645-53. DOI: 10.1016/s0016-5085(96)70028-8. View

Sonsuz A, Basaranoglu M, Ozbay G . Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2000; 95(5):1370-1. DOI: 10.1111/j.1572-0241.2000.02046.x. View

Fan J . [Therapeutic strategies for nonalcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi. 2003; 11(2):111. View

Lu L, Zeng M, Li J, Hua J, Fan J, Fan Z . Effect of lipid on proliferation and activation of rat hepatic stellate cells (I). World J Gastroenterol. 2002; 4(6):497-499. PMC: 4723437. DOI: 10.3748/wjg.v4.i6.497. View

. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology. 2002; 123(5):1702-4. DOI: 10.1053/gast.2002.36569. View

Koteish A, Diehl A . Animal models of steatosis. Semin Liver Dis. 2001; 21(1):89-104. DOI: 10.1055/s-2001-12932. View

10.

Fang J, Fan J . [Current therapy strategies for nonalcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi. 2003; 11(2):120-2. View

11.

. Nonalcoholic steatohepatitis clinical research network. Hepatology. 2003; 37(2):244. DOI: 10.1002/hep.510370203. View

12.

Fan J, Zhong L, Wang G, Wu X, Li M, Jing D . The role of Kupffer cells in non-alcoholic steatohepatitis of rats chronically fed with high-fat diet. Zhonghua Gan Zang Bing Za Zhi. 2001; 9(1):16-8. View

13.

Biourge V, Groff J, Fisher C, Bee D, Morris J, Rogers Q . Nitrogen balance, plasma free amino acid concentrations and urinary orotic acid excretion during long-term fasting in cats. J Nutr. 1994; 124(7):1094-103. DOI: 10.1093/jn/124.7.1094. View

14.

Eriksson S, Eriksson K, Bondesson L . Nonalcoholic steatohepatitis in obesity: a reversible condition. Acta Med Scand. 1986; 220(1):83-8. DOI: 10.1111/j.0954-6820.1986.tb02733.x. View

15.

Angulo P . Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16):1221-31. DOI: 10.1056/NEJMra011775. View

16.

Fan J, Xu Z, Wang G, Ding X, Tian L, Zheng X . [Change of serum endotoxin level in the progress of nonalcoholic steatohepatitis in rats]. Zhonghua Gan Zang Bing Za Zhi. 2003; 11(2):73-6. View

17.

Angulo P, Lindor K . Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis. 2001; 21(1):81-8. DOI: 10.1055/s-2001-12931. View

18.

Sanyal A . AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 2002; 123(5):1705-25. DOI: 10.1053/gast.2002.36572. View

19.

Knodell R, Ishak K, Black W, Chen T, Craig R, Kaplowitz N . Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1(5):431-5. DOI: 10.1002/hep.1840010511. View

20.

Biourge V, Groff J, MUNN R, Kirk C, Nyland T, Madeiros V . Experimental induction of hepatic lipidosis in cats. Am J Vet Res. 1994; 55(9):1291-302. View